IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

November 10-14, 2021

The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting & Pre-Conference Programs (SITC)

Dr. Alice Bexon, Vyriad, Chief Medical Officer; Vino Raj, Vyriad, Medical Director; and Rebecca Thomason, Vyriad, Clinical Program Manager, will be attending the 36th SITC meeting in Washington, DC

Visit event site

Media Inquiries

For inquiries, please contact mediarelations@vyriad.com